Related Experiment Video
Updated: Aug 22, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Analysis of aberrant miRNA-mRNA interaction networks in prostate cancer to conjecture its molecular mechanisms
Shuang Peng1,1, Cheng Liu2,1, Xingchen Fan1,1
1Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Background:
MicroRNAs (miRNAs) capable of post-transcriptionally regulating mRNA expression are essential to tumor occurrence and progression.
Objective:
This study aims to find negatively regulatory miRNA-mRNA pairs in prostate adenocarcinoma (PRAD).
Methods:
Combining The Cancer Genome Atlas (TCGA) RNA-Seq data with Gene Expression Omnibus (GEO) mRNA/miRNA expression profiles, differently expressed miRNA/mRNA (DE-miRNAs/DE-mRNAs) were identified. MiRNA-mRNA pairs were screened by miRTarBase and TarBase, databases collecting experimentally confirmed miRNA-mRNA pairs, and verified in 30 paired prostate specimens by real-time reverse transcription polymerase chain reaction (RT-qPCR). The diagnostic values of miRNA-mRNA pairs were measured by receiver operation characteristic (ROC) curve and Decision Curve Analysis (DCA). DAVID-mirPath database and Connectivity Map were employed in GO/KEGG analysis and compounds research. Interactions between miRNA-mRNA pairs and phenotypic features were analyzed with correlation heatmap in hiplot.
Results:
Based on TCGA RNA-Seq data, 22 miRNA and 14 mRNA GEO datasets, 67 (20 down and 47 up) miRNAs and 351 (139 up and 212 down) mRNAs were selected. After screening from 2 databases, 8 miRNA (up)-mRNA (down) and 7 miRNA (down)-mRNA (up) pairs were identified with Pearson's correlation in TCGA. By external validation, miR-221-3p (down)/GALNT3 (up) and miR-20a-5p (up)/FRMD6 (down) were chosen. The model combing 4 signatures possessed better diagnostic value. These two miRNA-mRNA pairs were significantly connected with immune cells fraction and tumor immune microenvironment.
Conclusions:
The diagnostic model containing 2 negatively regulatory miRNA-mRNA pairs was established to distinguish PRADs from normal controls.
Insights
This study identifies two key microRNA-messenger RNA (miRNA-mRNA) pairs that can help diagnose prostate adenocarcinoma (PRAD). These negatively regulatory pairs are crucial for understanding tumor progression and developing diagnostic tools for PRAD.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- MicroRNAs (miRNAs) are critical regulators of gene expression, influencing tumor development and progression.
- Understanding miRNA-mRNA interactions is key to deciphering cancer mechanisms.
Purpose of the Study:
- To identify negatively regulatory microRNA-messenger RNA (miRNA-mRNA) pairs in prostate adenocarcinoma (PRAD).
- To establish a diagnostic model for PRAD based on these miRNA-mRNA interactions.
Main Methods:
- Integrated analysis of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets to identify differentially expressed miRNAs and mRNAs.
- Screening and validation of miRNA-mRNA pairs using experimental databases (miRTarBase, TarBase) and RT-qPCR.
- Assessment of diagnostic value using Receiver Operating Characteristic (ROC) curve and Decision Curve Analysis (DCA).
Main Results:
- Identified 67 differentially expressed miRNAs and 351 differentially expressed mRNAs.
- Selected two significant negatively regulatory miRNA-mRNA pairs: miR-221-3p/GALNT3 and miR-20a-5p/FRMD6.
- These pairs showed significant associations with immune cell fractions and the tumor immune microenvironment.
Conclusions:
- A diagnostic model incorporating two negatively regulatory miRNA-mRNA pairs was developed.
- This model effectively distinguishes prostate adenocarcinoma from normal tissues.
- The identified pairs offer potential as biomarkers for PRAD diagnosis.
More Related Videos
Related Concept Videos
MicroRNAs
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

